CNTX · Forms 3, 4, 5
Insider trades at Context Therapeutics Inc.
No open-market insider buys or sells at Context Therapeutics Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Context Therapeutics Inc. (CNTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Context Therapeutics Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Andy Pasternak | Director | Options or other derivatives | Form 4 | ||||
| Jennifer Evans Stacey | Director | Options or other derivatives | Form 4 | ||||
| Linda West | Director | Options or other derivatives | Form 4 | ||||
| Karen L. Smith | Director | Options or other derivatives | Form 4 | ||||
| Luke Nathaniel Walker | Director | Options or other derivatives | Form 4 | ||||
| Philip W. Kantoff | Director | Options or other derivatives | Form 4 | ||||
| Alex C. Levit | Chief Legal Officer, Corp. Sec | Options or other derivatives | Form 4 | ||||
| Jennifer Lynn Minai-Azary | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Karen Deborah Chagin | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Martin A. Lehr | Chief Executive Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.